Literature DB >> 9604057

Consensus development statement on osteoporosis.

O H Sørensen, S P Nielsen, P Charles, E F Eriksen, L Mosekilde, R P Heaney, J Falch, J Halse, E Haug.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9604057     DOI： 10.1007/bf02652567

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  4 in total

Review 1.  Who are candidates for prevention and treatment for osteoporosis?

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Biological variation of biochemical bone markers.

Authors:  J E Jensen; H A Sørensen; G Kollerup; L B Jensen; O H Sørensen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1994

3.  Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist?

Authors:  C Hassager; S B Jensen; C Christiansen
Journal:  Osteoporos Int       Date:  1994-01       Impact factor: 4.507

4.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.